Cargando…
Identification and validation of an E2F-related gene signature for predicting recurrence-free survival in human prostate cancer
BACKGROUND: It is well-established that biochemical recurrence is detrimental to prostate cancer (PCa). In the present study, we explored the mechanisms underlying PCa progression. METHODS: Five cohorts from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus databases were used to perform ge...
Autores principales: | Yang, Cheng, Chen, Lei, Niu, Qingsong, Ge, Qintao, Zhang, Jiong, Tao, Junyue, Zhou, Jun, Liang, Chaozhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721026/ https://www.ncbi.nlm.nih.gov/pubmed/36471446 http://dx.doi.org/10.1186/s12935-022-02791-9 |
Ejemplares similares
-
Overexpression of DDX49 in prostate cancer is associated with poor prognosis
por: Tao, Junyue, et al.
Publicado: (2023) -
In silico validation of a new classifier, PCSCG(ier), for predicting recurrence‐free survival in prostate cancer patients: Evidence from multiple datasets
por: Zhang, Meng, et al.
Publicado: (2023) -
Establishment of a five‐enzalutamide‐resistance‐related‐gene‐based classifier for recurrence‐free survival predicting of prostate cancer
por: Chen, Jing, et al.
Publicado: (2022) -
Cyclin D3 predicts disease-free survival in breast cancer
por: Chi, Yayun, et al.
Publicado: (2015) -
Identification and validation of methylation-driven genes prognostic signature for recurrence of laryngeal squamous cell carcinoma by integrated bioinformatics analysis
por: Cui, Jie, et al.
Publicado: (2020)